OpenAI releases GPT-6 Rosalind, a biology research AI open only to approved labs
The model is meant for early drug discovery and genetics work and is limited because of biological safety concerns.
OpenAI said Oct. 30 that it has released GPT-6 Rosalind, an AI model built for biology research. The San Francisco company said it combines biological reasoning with the ability to use scientific software and databases.
Only a limited set of approved research organizations can use it, OpenAI said. Groups apply through a trusted-access program, a review OpenAI uses for tools that could be misused, and even approved users must pass extra checks for the newest model.
OpenAI's help page says the Rosalind models are most useful in early discovery, such as finding which genes or proteins a drug might target, summarizing research papers and making sense of genetic data. It names computational biologists among the main users.
Approved groups can use it in ChatGPT's Work mode, in Codex, OpenAI's coding tool, and through its API, the connection programmers use, where separately approved.
Source: OpenAI API changelog, Oct. 30, 2026; OpenAI Help Center, "GPT-Rosalind for life sciences research".